INS and Hyperkalemia: In patients receiving insulin–dextrose infusions for the treatment of hyperkalaemia, the median time from the first infusion to the first emergency HD session in the control group was 2.9 days (IQR 2.1–5.7) compared with 3.1 days (IQR 2.4–6.3) in the treatment group.